|
1
|
Boels MGS, Koudijs A, Avramut MC, Sol
WMPJ, Wang G, van Oeveren-Rietdijk AM, van Zonneveld AJ, de Boer
HC, van der Vlag J, van Kooten C, et al: Systemic monocyte
chemotactic protein-1 inhibition modifies renal macrophages and
restores glomerular endothelial glycocalyx and barrier function in
diabetic nephropathy. Am J Pathol. 187:2430–2440. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Song K, Fu J, Song J, Herzog BH, Bergstrom
K, Kondo Y, McDaniel JM, McGee S, Silasi-Mansat R, Lupu F, et al:
Loss of mucin-type O-glycans impairs the integrity of the
glomerular filtration barrier in the mouse kidney. J Biol Chem.
292:16491–16497. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Qi H, Casalena G, Shi S, Yu L, Ebefors K,
Sun Y, Zhang W, D'Agati V, Schlondorff D, Haraldsson B, et al:
Glomerular endothelial mitochondrial dysfunction is essential and
characteristic of diabetic kidney disease susceptibility. Diabetes.
66:763–778. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kusano T, Takano H, Kang D, Nagahama K,
Aoki M, Morita M, Kaneko T, Tsuruoka S and Shimizu A: Endothelial
cell injury in acute and chronic glomerular lesions in patients
with IgA nephropathy. Hum Pathol. 49:135–144. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Salmon AH and Satchell SC: Endothelial
glycocalyx dysfunction in disease: Albuminuria and increased
microvascular permeability. J Pathol. 226:562–574. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lavoz C, Matus YS, Orejudo M, Carpio JD,
Droguett A, Egido J, Mezzano S and Ruiz-Ortega M: Interleukin-17A
blockade reduces albuminuria and kidney injury in an accelerated
model of diabetic nephropathy. Kidney Int. 95:1418–1432.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dial AG, Ng SY, Manta A and Ljubicic V:
The role of AMPK in neuromuscular biology and disease. Trends
Endocrinol Metab. 29:300–312. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Packer M: Interplay of adenosine
monophosphate-activated protein kinase/sirtuin-1 activation and
sodium influx inhibition mediates the renal benefits of
sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: A
novel conceptual framework. Diabetes Obes Metab. 22:734–742.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lee MJ, Feliers D, Mariappan MM,
Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B,
Weinberg JM, Choudhury GG and Kasinath BS: A role for AMP-activated
protein kinase in diabetes-induced renal hypertrophy. Am J Physiol
Renal Physiol. 292:F617–F627. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Eid AA, Ford BM, Block K, Kasinath BS,
Gorin Y, Ghosh-Choudhury G, Barnes JL and Abboud HE: AMP-activated
protein kinase (AMPK) negatively regulates Nox4-dependent
activation of p53 and epithelial cell apoptosis in diabetes. J Biol
Chem. 285:37503–37512. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Eisenreich A and Leppert U: Update on the
protective renal effects of metformin in diabetic nephropathy. Curr
Med Chem. 24:3397–3412. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Alhaider AA, Korashy HM, Sayed-Ahmed MM,
Mobark M, Kfoury H and Mansour MA: Metformin attenuates
streptozotocin-induced diabetic nephropathy in rats through
modulation of oxidative stress genes expression. Chem Biol
Interact. 192:233–242. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang J, Kong X, Wang Z, Gao X, Ge Z, Gu
Y, Ye P, Chao Y, Zhu L, Li X and Chen S: AMP-activated protein
kinase regulates glycocalyx impairment and macrophage recruitment
in response to low shear stress. FASEB J. 33:7202–7212.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jianzhi S, Qizeng W, Bin L, Wenhui L,
Yunpeng C, Chenrong F, Lin Z and Huiting C: Piperazine ferulate
exerts antihypertensive effect and improves endothelial function in
vitro and in vivo via the activation of endothelial nitric oxide
synthase. Cell Mol Biol (Noisy-le-grand). 65:119–124.
2019.PubMed/NCBI
|
|
15
|
Liu Z, Pan J, Sun C, Zhou J and Li NA:
Clinical effects of perazine ferulate tablets combined with
eucalyptol limonene pinene enteric soft capsules for treatment of
children with IgA nephropathy. Exp Ther Med. 12:169–172.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yang YY, Shi LX, Li JH, Yao LY and Xiang
DX: Piperazine ferulate ameliorates the development of diabetic
nephropathy by regulating endothelial nitric oxide synthase. Mol
Med Rep. 19:2245–2253. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li D, Li B, Peng LX, Liu R and Zeng N:
Therapeutic efficacy of piperazine ferulate combined with
irbesartan in diabetic nephropathy: A systematic review and
meta-analysis. Clin Ther. 42:2196–2212. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang YY, Deng RR, Chen Z, Yao LY, Yang XD
and Xiang DX: Piperazine ferulate attenuates high glucose-induced
mesangial cell injury via the regulation of p66Shc. Mol
Med Rep. 23(374)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jones-Bolin S: Guidelines for the care and
use of laboratory animals in biomedical research. Curr Protoc
Pharmacol Appendix. 4(Appendix4B)2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yu S, Lv H, Zhang H, Jiang Y, Hong Y, Xia
R, Zhang Q, Ju W, Jiang L, Ou G, et al: Heparanase-1-induced
shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell
facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK
pathway. Biochem Biophys Res Commun. 485:432–439. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zafrani L and Ince C: Microcirculation in
acute and chronic kidney diseases. Am J Kidney Dis. 66:1083–1094.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Okada H, Yoshida S, Hara A, Ogura S and
Tomita H: Vascular endothelial injury exacerbates coronavirus
disease 2019: The role of endothelial glycocalyx protection.
Microcirculation. 28(e12654)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhu T, Wang H, Wang L, Zhong X, Huang W,
Deng X, Guo H, Xiong J, Xu Y and Fan J: Ginsenoside Rg1 attenuates
high glucose-induced endothelial barrier dysfunction in human
umbilical vein endothelial cells by protecting the endothelial
glycocalyx. Exp Ther Med. 17:3727–3733. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fukui M, Yamada M, Akune Y, Shigeyasu C
and Tsubota K: Fluorophotometric analysis of the ocular surface
glycocalyx in soft contact lens wearers. Curr Eye Res. 41:9–14.
2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang Y, Macleod V, Miao HQ, Theus A, Zhan
F, Shaughnessy JD Jr, Sawyer J, Li JP, Zcharia E, Vlodavsky I and
Sanderson RD: Heparanase enhances syndecan-1 shedding: A novel
mechanism for stimulation of tumor growth and metastasis. J Biol
Chem. 282:13326–13333. 2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rangarajan S, Richter JR, Richter RP,
Bandari SK, Tripathi K, Vlodavsky I and Sanderson RD:
Heparanase-enhanced shedding of syndecan-1 and its role in driving
disease pathogenesis and progression. J Histochem Cytochem.
68:823–840. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Singh A, Friden V, Dasgupta I, Foster RR,
Welsh GI, Tooke JE, Haraldsson B, Mathieson PW and Satchell SC:
High glucose causes dysfunction of the human glomerular endothelial
glycocalyx. Am J Physiol Renal Physiol. 300:F40–F48.
2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Reine TM, Lanzalaco F, Kristiansen O,
Enget AR, Satchell S, Jenssen TG and Kolset SO: Matrix
metalloproteinase-9 mediated shedding of syndecan-4 in glomerular
endothelial cells. Microcirculation: Jan 31, 2019 (Epub ahead of
print).
|
|
30
|
Eftekhari A, Vahed SZ, Kavetskyy T,
Rameshrad M, Jafari S, Chodari L, Hosseiniyan SM, Derakhshankhah H,
Ahmadian E and Ardalan M: Cell junction proteins: Crossing the
glomerular filtration barrier in diabetic nephropathy. Int J Biol
Macromol. 148:475–482. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Rincon-Choles H, Vasylyeva TL, Pergola PE,
Bhandari B, Bhandari K, Zhang JH, Wang W, Gorin Y, Barnes JL and
Abboud HE: ZO-1 expression and phosphorylation in diabetic
nephropathy. Diabetes. 55:894–900. 2006.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ha TS, Choi JY, Park HY and Lee JS:
Ginseng total saponin improves podocyte hyperpermeability induced
by high glucose and advanced glycosylation endproducts. J Korean
Med Sci. 26:1316–1321. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kim Y and Park CW: New therapeutic agents
in diabetic nephropathy. Korean J Intern Med. 32:11–25.
2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kim Y and Park CW: Adenosine
monophosphate-activated protein kinase in diabetic nephropathy.
Kidney Res Clin Pract. 35:69–77. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Morales-Alamo D and Calbet JA: AMPK
signaling in skeletal muscle during exercise: Role of reactive
oxygen and nitrogen species. Free Radic Biol Med. 98:68–77.
2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sharma K, Ramachandrarao S, Qiu G, Usui
HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, et al:
Adiponectin regulates albuminuria and podocyte function in mice. J
Clin Invest. 118:1645–1656. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zheng B and Cantley LC: Regulation of
epithelial tight junction assembly and disassembly by AMP-activated
protein kinase. Proc Natl Acad Sci USA. 104:819–822.
2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Chen X, Guo Y, Jia G, Zhao H, Liu G and
Huang Z: Ferulic acid regulates muscle fiber type formation through
the Sirt1/AMPK signaling pathway. Food Funct. 10:259–265.
2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Giovannini L and Bianchi S: Role of
nutraceutical SIRT1 modulators in AMPK and mTOR pathway: Evidence
of a synergistic effect. Nutrition. 34:82–96. 2017.PubMed/NCBI View Article : Google Scholar
|
